In a pilot study, we have shown that a human OSCC tumor cell line treated with transforming growth factor beta (TGF-β) upregulates SOST gene expression and that sclerostin protein expression has a significant prognostic impact on patients [32]. This evidence concerns the gene SOST and neoplasm.